María Borrell

1.4k total citations
22 papers, 343 citations indexed

About

María Borrell is a scholar working on Economics and Econometrics, Molecular Biology and Oncology. According to data from OpenAlex, María Borrell has authored 22 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Economics and Econometrics, 4 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in María Borrell's work include Health Systems, Economic Evaluations, Quality of Life (4 papers), Economic and Financial Impacts of Cancer (4 papers) and Platelet Disorders and Treatments (2 papers). María Borrell is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (4 papers), Economic and Financial Impacts of Cancer (4 papers) and Platelet Disorders and Treatments (2 papers). María Borrell collaborates with scholars based in Spain, United States and Canada. María Borrell's co-authors include José Mateo, Lina Badimón, Arturo Oliver, Isabel Tirado, Jordi Fontcuberta, José Manuel Soria, Andri Papakonstantinou, Mafalda Oliveira, J. Fontcuberta and Núria Sala and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cardiovascular Research.

In The Last Decade

María Borrell

17 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
María Borrell Spain 9 130 66 63 51 45 22 343
Cyril Cyrus Saudi Arabia 12 72 0.6× 97 1.5× 74 1.2× 64 1.3× 25 0.6× 42 396
Cyrus C. Hsia Canada 11 258 2.0× 69 1.0× 31 0.5× 42 0.8× 10 0.2× 83 541
Sumit Kunwar United States 6 47 0.4× 33 0.5× 69 1.1× 203 4.0× 16 0.4× 7 416
K Deguchi Japan 14 217 1.7× 45 0.7× 77 1.2× 82 1.6× 76 1.7× 32 439
John Houghton United Kingdom 10 109 0.8× 51 0.8× 34 0.5× 35 0.7× 27 0.6× 26 389
M. Sata Japan 10 149 1.1× 86 1.3× 84 1.3× 105 2.1× 21 0.5× 11 393
Vibeke Bratseth Norway 9 40 0.3× 139 2.1× 42 0.7× 159 3.1× 25 0.6× 25 327
Shigenori Kanazawa Japan 11 132 1.0× 157 2.4× 28 0.4× 76 1.5× 26 0.6× 23 419
P. M. van der Zee Netherlands 8 59 0.5× 120 1.8× 31 0.5× 169 3.3× 22 0.5× 14 336
Larisa Dzirlo Austria 5 240 1.8× 26 0.4× 34 0.5× 57 1.1× 11 0.2× 10 357

Countries citing papers authored by María Borrell

Since Specialization
Citations

This map shows the geographic impact of María Borrell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by María Borrell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites María Borrell more than expected).

Fields of papers citing papers by María Borrell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by María Borrell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by María Borrell. The network helps show where María Borrell may publish in the future.

Co-authorship network of co-authors of María Borrell

This figure shows the co-authorship network connecting the top 25 collaborators of María Borrell. A scholar is included among the top collaborators of María Borrell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with María Borrell. María Borrell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Navarro‐Sabaté, Àurea, Rebeca Font, Josep Alfons Espinàs, et al.. (2025). Evaluating the Quality of Real-World Data on Adherence to Oral Endocrine Therapy in Breast Cancer Patients: How Real Is Real-World Data?. Cancers. 17(2). 200–200. 1 indexed citations
2.
Vilahur, Gemma, Soumaya Ben‐Aicha, Manuel Gutiérrez, et al.. (2025). Cardioprotection exerted by intravenous statin at index myocardial infarction event attenuates cardiac damage upon recurrent infarction. Cardiovascular Research. 121(2). 283–295. 3 indexed citations
3.
Borrell, María, Ricard Cervera, F. Figueras, et al.. (2025). Non-Criteria Obstetric Antiphospholipid Syndrome: Myth or Reality?. Journal of Clinical Medicine. 14(4). 1299–1299.
4.
Tibau, Ariadna, et al.. (2025). Predictors of withdrawal of anticancer drug indications granted accelerated approval: a retrospective cohort study. EClinicalMedicine. 84. 103088–103088. 1 indexed citations
5.
Youssef, L., Patricia Molina, Julia Martínez-Sánchez, et al.. (2025). Endothelial damage and complement dysregulation in fetuses from pregnancies complicated by preeclampsia. Acta Obstetricia Et Gynecologica Scandinavica. 104(5). 829–838. 2 indexed citations
6.
Borrell, María, et al.. (2025). Psychological Impact in Early Pregnancy Loss: The Effects of Disclosing the Causative Chromosomal Anomaly. Fetal Diagnosis and Therapy. 52(4). 377–387.
7.
Magaldi, Marta, Teresa Padró, María Borrell, et al.. (2025). Differential regulation of the HIF-1α/apoptosis axis by miR-126-5p in cardiac cells during ischemia/reperfusion injury. Clínica e Investigación en Arteriosclerosis. 500842–500842.
8.
Hwang, Thomas J., et al.. (2025). Factors in Time to Full Approval or Withdrawal for Anticancer Medicines Granted Accelerated Approval by the FDA. JAMA Network Open. 8(3). e252026–e252026. 4 indexed citations
9.
Papakonstantinou, Andri, et al.. (2024). Use of ctDNA in early breast cancer: analytical validity and clinical potential. npj Breast Cancer. 10(1). 50–50. 38 indexed citations
10.
Papakonstantinou, Andri, Paolo Nucíforo, María Borrell, et al.. (2022). The conundrum of breast cancer and microbiome - A comprehensive review of the current evidence. Cancer Treatment Reviews. 111. 102470–102470. 28 indexed citations
11.
Hwang, Thomas J., María Borrell, Ignasi Gich, et al.. (2020). Clinical benefit and cost of breakthrough cancer drugs approved by the US Food and Drug Administration. Cancer. 126(19). 4390–4399. 25 indexed citations
12.
López–Pousa, Antonio, Jacinto Garcı́a, Núria Farré, et al.. (2019). Risk of second primary neoplasia in patients with oropharyngeal carcinoma: Role of HPV status in the outcome.. Journal of Clinical Oncology. 37(15_suppl). e17544–e17544.
13.
Hwang, Thomas J., María Borrell, A. Barnadas, et al.. (2019). Clinical benefit of breakthrough cancer drugs approved by the United States Food and Drug Administration.. Journal of Clinical Oncology. 37(15_suppl). 6513–6513. 1 indexed citations
14.
Badimón, Lina & María Borrell. (2018). Microvasculature Recovery by Angiogenesis After Myocardial Infarction. Current Pharmaceutical Design. 24(25). 2967–2973. 37 indexed citations
15.
Vilahur, Gemma, Laura Casaní, Esther Peña, et al.. (2018). Silybum marianum provides cardioprotection and limits adverse remodeling post-myocardial infarction by mitigating oxidative stress and reactive fibrosis. International Journal of Cardiology. 270. 28–35. 26 indexed citations
16.
Casas, I., et al.. (2008). Determination of UO2(s) dissolution rates in a hydrogen peroxide medium as a function of pressure and temperature. Journal of Nuclear Materials. 375(1). 151–156. 5 indexed citations
17.
Tirado, Isabel, José Manuel Soria, Arturo Oliver, et al.. (2005). The ABO blood group genotype and factor VIII levels as independent risk factors for venous thromboembolism. Thrombosis and Haemostasis. 93(3). 468–474. 104 indexed citations
18.
Mateo, José, Arturo Oliver, María Borrell, Núria Sala, & J. Fontcuberta. (1998). Increased risk of venous thrombosis in carriers of natural anticoagulant deficiencies. Results of the family studies of the Spanish Multicenter Study on Thrombophilia (EMET study). Blood Coagulation & Fibrinolysis. 9(1). 71–78. 34 indexed citations
19.
Ordóñez, Antonio, et al.. (1995). [Exercise physiology and the rehabilitation of the heart transplant patient].. PubMed. 48 Suppl 7. 135–9. 1 indexed citations
20.
Mateo, José, et al.. (1993). Acquired factor VIII inhibitor preceding chronic lymphocytic leukemia. Annals of Hematology. 67(6). 309–311. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cyril Cyrus Breakdown of academic impact, for papers by Cyrus C. Hsia Breakdown of academic impact, for papers by Sumit Kunwar Breakdown of academic impact, for papers by K Deguchi Breakdown of academic impact, for papers by John Houghton Breakdown of academic impact, for papers by M. Sata Breakdown of academic impact, for papers by Vibeke Bratseth Breakdown of academic impact, for papers by Shigenori Kanazawa Breakdown of academic impact, for papers by P. M. van der Zee Breakdown of academic impact, for papers by Larisa Dzirlo
Rankless by CCL
2026